Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (6 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
2 selected
)
Type
Guidance (219)
Quality standard (0)
Guidance programme
(
3 selected
)
Guidance programme
Antimicrobial prescribing guidelines (2)
Clinical guidelines (45)
Diagnostics guidance (6)
Health technology evaluations (3)
Highly specialised technologies guidance (8)
Interventional procedures guidance (63)
Medical technologies guidance (27)
NICE guidelines (57)
Public health guidelines (7)
Social care guidelines (9)
Technology appraisal guidance (186)
Apply filters
Showing 41 to 50 of 219
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2021 and 31/3/2023
Remove Last updated date between 1/4/2021 and 31/3/2023 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal)
TA840
16 November 2022
16 November 2022
Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal)
TA838
2 November 2022
2 November 2022
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma
TA837
26 October 2022
26 October 2022
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
TA836
26 October 2022
26 October 2022
Pembrolizumab for adjuvant treatment of renal cell carcinoma
TA830
19 October 2022
19 October 2022
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
TA832
19 October 2022
19 October 2022
Zanubrutinib for treating Waldenstrom's macroglobulinaemia
TA833
19 October 2022
19 October 2022
Fostamatinib for treating refractory chronic immune thrombocytopenia
TA835
19 October 2022
19 October 2022
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal)
TA834
12 October 2022
12 October 2022
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer
MTG72
5 October 2022
5 October 2022
Previous page
1
…
3
4
Current page
5
6
7
…
22
Page
5
of
22
Next page
Results per page
10
25
50
All
Back to top